Jaguar Health, Inc. (JAGX) Form 424B3 — Jul 27, 2026
Jaguar Health filed a prospectus supplement for the resale of up to 40,874,552 shares of common stock by C/M Capital Master Fund, LP. The shares relate to an Equity Line of Credit (ELOC) established on June 9, 2026, wherein C/M Capital committed to purchase up to $40 million of the company's stock. The registered shares include up to 40 million purchase shares issuable at the company's discretion and approximately 874,000 commitment shares issued as consideration for the agreement. The ELOC includes a floor price of $1.10 per share, meaning the company cannot draw funds unless the stock trades at or above that level.
Key figures
- Gross Proceeds
- Up to $40,000,000 (ELOC capacity)
- Shares Offered
- 40874552
- Shares Outstanding
- 4910402
- Floor price
- $1.10
- Ownership cap
- 4.99%
- Current trading price
- $0.9633
- Commitment shares issued
- 257898
- Commitment shares issuable
- 616654
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.